bw 501c has been researched along with quipazine in 4 studies
| Studies (bw 501c) | Trials (bw 501c) | Recent Studies (post-2010) (bw 501c) | Studies (quipazine) | Trials (quipazine) | Recent Studies (post-2010) (quipazine) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 658 | 0 | 41 |
| Protein | Taxonomy | bw 501c (IC50) | quipazine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 1.4454 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.47 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 1.4 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.7 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0617 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 3.7297 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.0035 | |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 3.7153 | |
| Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | 1.4454 | |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 2A | Bos taurus (cattle) | 3.4674 | |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ | 1 |
| Cohen, ML; Fuller, RW; Kurz, KD; Mason, NR | 1 |
| Ellam, LD; Harrison, MJ | 1 |
| Knowles, ID; Ramage, AG | 1 |
4 other study(ies) available for bw 501c and quipazine
| Article | Year |
|---|---|
The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.
Topics: Amidines; Anesthesia; Animals; Blood Pressure; Carotid Body; Denervation; Heart Rate; Hemodynamics; Hexamethonium Compounds; In Vitro Techniques; Indoles; Lung; Male; Myocardium; Piperidines; Prazosin; Pressoreceptors; Propanolamines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Renin-Angiotensin System; Ritanserin; Sympathetic Nervous System; Thiophenes; Tropisetron; Vagotomy | 1990 |
Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.
Topics: Amidines; Animals; Blood Pressure; Cerebral Cortex; Corticosterone; Decerebrate State; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Quipazine; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1986 |
Role of 5HT in the morbidity of cerebral infarction-a study in the gerbil stroke model.
Topics: 5-Hydroxytryptophan; Amidines; Animals; Brain Chemistry; Cerebral Infarction; Cyproheptadine; Fenclonine; Gerbillinae; Metergoline; Methysergide; Pargyline; Quipazine; Serotonin; Serotonin Antagonists | 1981 |
Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats.
Topics: Amidines; Amphetamines; Animals; Antidiuretic Hormone Receptor Antagonists; Atropine Derivatives; Blood Pressure; Cardiovascular Physiological Phenomena; Cinanserin; Injections, Intraventricular; Male; Polyethylene Glycols; Quipazine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Antagonists; Spiperone | 1999 |